45 CFR § 180 compliance
B · 85
This hospital published most of what § 180 requires.
●Machine-readable file published
●Gross / standard charges
●Discounted cash price
●Payer-specific negotiated rates
○Min / max negotiated charges
●Free, public, no login required
Procedures listed
5,597
Insurances with rates
12
CPT / HCPCS codes
0
Source MRF
Most expensive procedures (gross)
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| RX-346382 | LUTETIUM LU 177 DOTATATE 370 MBQ/ML IV SOLN | $362,040 | $188,768 | — | — | 8 |
| RX-339056 | RADIUM RA 223 DICHLORIDE 30 MCCI/ML IV SOLN | $135,443 | $70,620 | — | — | 9 |
| RX-255737 | PEGASPARGASE 750 UNIT/ML IJ SOLN | $135,194 | $70,490 | — | — | 10 |
| 480 | Hip And Femur Procedures Except Major Joint With McC | $118,032 | $61,542 | — | — | 6 |
| 331 | Major Small And Large Bowel Procedures Without Cc/McC | $106,841 | $55,707 | — | — | 6 |
| RX-373211 | OCRELIZUMAB-HYALURONIDASE-OCSQ 920-23000 MG-UT/23ML SC SOLN | $104,289 | $54,376 | — | — | 9 |
| RX-365419 | TREMELIMUMAB-ACTL 300 MG/15ML IV SOLN | $101,873 | $53,117 | — | — | 9 |
| 371 | Major Gastrointestinal Disorders And Peritoneal Infections With McC | $99,467 | $51,862 | — | — | 6 |
| 622 | Skin Grafts And Wound Debridement For Endocrine, Nutritional And Metabolic Disorders With McC | $90,982 | $47,438 | — | — | 6 |
| RX-313560 | IPILIMUMAB 200 MG/40ML IV SOLN | $88,724 | $46,261 | — | — | 10 |
| 521 | Hip Replacement With Principal Diagnosis Of Hip Fracture With McC | $86,607 | $45,157 | — | — | 6 |
| RX-350177 | TAGRAXOFUSP-ERZS 1000 MCG/ML IV SOLN | $81,076 | $42,273 | — | — | 9 |
| 330 | Major Small And Large Bowel Procedures With Cc | $71,299 | $37,175 | — | — | 6 |
| RX-359644 | LONCASTUXIMAB TESIRINE-LPYL 10 MG IV SOLR | $69,732 | $36,358 | — | — | 9 |
| RX-430359644 | LONCASTUXIMAB TESIRINE-LPYL 10 MG/2ML IV (WET SOLR VIAL) | $69,732 | $36,358 | — | — | 9 |
| 399 | Appendix Procedures Without Cc/McC | $62,250 | $32,457 | — | — | 6 |
| 909 | Other O.R. Procedures For Injuries Without Cc/McC | $59,088 | $30,808 | — | — | 6 |
| RX-344974 | INOTUZUMAB OZOGAMICIN 0.9 MG IV SOLR | $58,607 | $30,558 | — | — | 10 |
| RX-430344974 | INOTUZUMAB OZOGAMICIN 0.9 MG/3.6ML IV (WET SOLR VIAL) | $58,607 | $30,558 | — | — | 10 |
| 481 | Hip And Femur Procedures Except Major Joint With Cc | $57,788 | $30,131 | — | — | 6 |
| 336 | Peritoneal Adhesiolysis With Cc | $56,229 | $29,318 | — | — | 6 |
| RX-342976 | CANAKINUMAB 150 MG/ML SC SOLN | $53,872 | $28,089 | — | — | 10 |
| RX-361122 | PALIPERIDONE PALMITATE ER 1560 MG/5ML IM SUSY | $52,690 | $27,473 | — | — | 9 |
| RX-343282 | OCRELIZUMAB 300 MG/10ML IV SOLN | $52,175 | $27,204 | — | — | 10 |
| 522 | Hip Replacement With Principal Diagnosis Of Hip Fracture Without McC | $47,968 | $25,011 | — | — | 6 |
| RX-351870 | POLATUZUMAB VEDOTIN-PIIQ 140 MG IV SOLR | $47,408 | $24,719 | — | — | 9 |
| RX-430351870 | POLATUZUMAB VEDOTIN-PIIQ 140 MG/7ML IV (WET SOLR VIAL) | $47,408 | $24,719 | — | — | 9 |
| RX-366179 | MOSUNETUZUMAB-AXGB 30 MG/30ML IV SOLN | $46,535 | $24,263 | — | — | 9 |
| 788 | Cesarean Section Without Sterilization Without Cc/McC | $46,091 | $24,032 | — | — | 6 |
| RX-362065 | EFGARTIGIMOD ALFA-FCAB 400 MG/20ML IV SOLN | $45,643 | $23,798 | — | — | 10 |
| 417 | Laparoscopic Cholecystectomy Without C.D.E. With McC | $45,247 | $23,592 | — | — | 6 |
| 939 | O.R. Procedures With Diagnoses Of Other Contact With Health Services With McC | $44,718 | $23,316 | — | — | 0 |
| 787 | Cesarean Section Without Sterilization With Cc | $44,339 | $23,119 | — | — | 6 |
| 482 | Hip And Femur Procedures Except Major Joint Without Cc/McC | $43,355 | $22,605 | — | — | 6 |
| 494 | Lower Extremity And Humerus Procedures Except Hip, Foot And Femur Without Cc/McC | $42,639 | $22,232 | — | — | 6 |
| 580 | Other Skin, Subcutaneous Tissue And Breast Procedures With Cc | $42,562 | $22,192 | — | — | 6 |
| RX-361121 | PALIPERIDONE PALMITATE ER 1092 MG/3.5ML IM SUSY | $40,169 | $20,944 | — | — | 9 |
| RX-368110 | EFGARTIGIMOD ALFA-HYALUR-QVFC 180-2000 MG-UNIT/ML SC SOLN | $39,445 | $20,567 | — | — | 10 |
| 784 | Cesarean Section With Sterilization With Cc | $39,115 | $20,395 | — | — | 6 |
| 264 | Other Circulatory System O.R. Procedures | $37,985 | $19,805 | — | — | 6 |
| RX-362809 | NIVOLUMAB-RELATLIMAB-RMBW 240-80 MG/20ML IV SOLN | $37,813 | $19,716 | — | — | 10 |
| RX-313170 | PRALATREXATE 40 MG/2ML IV SOLN | $37,425 | $19,513 | — | — | 10 |
| 786 | Cesarean Section Without Sterilization With McC | $36,539 | $19,051 | — | — | 6 |
| RX-367032 | RETIFANLIMAB-DLWR 500 MG/20ML IV SOLN | $36,152 | $18,850 | — | — | 10 |
| 419 | Laparoscopic Cholecystectomy Without C.D.E. Without Cc/McC | $35,690 | $18,609 | — | — | 6 |
| 853 | Infectious And Parasitic Diseases With O.R. Procedures With McC | $34,592 | $18,036 | — | — | 6 |
| 768 | Vaginal Delivery With O.R. Procedures Except Sterilization And/Or D&C | $34,587 | $18,033 | — | — | 6 |
| 56 | Degenerative Nervous System Disorders With McC | $34,552 | $18,015 | — | — | 4 |
| 947 | Signs And Symptoms With McC | $34,009 | $17,732 | — | — | 2 |
| RX-310263 | CABAZITAXEL 60 MG/1.5ML IV SOLN | $33,346 | $17,387 | — | — | 10 |
Showing top 50 of 5,597 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.